GLP-1 Daily: Ozempic & Wegovy News
Mass General Brigham Drops Weight-Loss GLP-1 Coverage for Some Staff; MPs Call NHS Mounjaro Plan 'Woefully Small'; CBS Tests Bootleg Retatrutide
Friday, October 23, 2026 · 7 min
Mass General Brigham confirms affected employee plans will stop covering GLP-1s for weight loss on January 1, 2027, and British MPs say the NHS plan for Mounjaro reaches only about 6% of eligible people. CBS News lab-tested vials sold as retatrutide and found one held no peptide at all, plus bacteria.
Listen
Show notes
Mass General Brigham confirms affected employee plans will stop covering GLP-1s for weight loss on January 1, 2027, and British MPs say the NHS plan for Mounjaro reaches only about 6% of eligible people. CBS News lab-tested vials sold as retatrutide and found one held no peptide at all, plus bacteria.
In this episode
- EXCLUSIVE: Mass General Helped Give the World GLP-1. Now Its Own Benefits Are Pulling Back Obesity Drug Coverage | On The Pen — On The Pen GLP-1 News
“Beginning January 1, 2027, GLP-1 medications prescribed for weight loss will no longer be covered through the pharmacy benefit of affected Mass General Brigham employee medical plans. Coverage for GLP-1 medications prescribed for diabetes will continue, subject to plan coverage…”
- Give more people weight loss jabs on the NHS, say MPs - BBC News — BBC News
“The Health Committee said the current plan for 220,000 people to have this jab for free on prescription in 2028 was a "woefully small number" and "unambitious".”
- We bought and tested what was sold as an experimental weight loss drug. The lab results were "pretty terrifying." - CBS News — Adam Yamaguchi Correspondent
“Instead, Galpin found a compound called phenylacetic acid, which he described as a filler. It's commonly found in fragrances and lip balms.”